Picture loading failed.

Liraglutide TFA, the trifluoroacetic acid salt form of Liraglutide. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist also known as incretin mimetics. Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management. It works by increasing insulin release from the pancreas and decreases excessive glucagon release. Liraglutide was approved for medical use in the European Union in 2009, and in the United States in 2010.



Order information

Catalog No. Desciption Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-peptide-003-1-5mg Liraglutide (5-31) TFA Size:5mg 780
GMP-Bios-peptide-003-1-25mg Liraglutide (5-31) TFA Size:25mg 1950
GMP-Bios-peptide-003-1-50mg Liraglutide (5-31) TFA Size:50mg 2925
GMP-Bios-peptide-003-1-100mg Liraglutide (5-31) TFA Size:100mg 3900
GMP-Bios-peptide-003-1-500mg Liraglutide (5-31) TFA Size:500mg 7800
GMP-Bios-peptide-003-2-5mg Liraglutide (8-31) TFA Size:5mg 780
GMP-Bios-peptide-003-2-25mg Liraglutide (8-31) TFA Size:25mg 1950
GMP-Bios-peptide-003-2-50mg Liraglutide (8-31) TFA Size:50mg 2925
GMP-Bios-peptide-003-2-100mg Liraglutide (8-31) TFA Size:100mg 3900
GMP-Bios-peptide-003-2-500mg Liraglutide (8-31) TFA Size:500mg 7800
GMP-Bios-peptide-003-1/2-xmg Size≥500mg Inquiry
Shipping Cost: 760.00
Total:

For more than 500mg, click here for inquiry. >>


Description

Product NameLiraglutide (5-31) TFA / Liraglutide (8-31) TFA
Brand nameVictoza
CAS No.204656-20-2
FormulaC157H247N37O44 • C2HF3O2 / C140H224N34O39 • C2HF3O2
Biological ActivityLiraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist also known as incretin mimetics.
PurityPurity: ≥98% (HPLC)
ApplicationTherapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development.
Predicted Molecular Mass3356.86 / 3007.48
FormulationPowder
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.